Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.650
-0.010 (-0.60%)
At close: Jul 17, 2026, 4:00 PM EDT
1.710
+0.060 (3.64%)
After-hours: Jul 17, 2026, 7:34 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $163.65 million as of July 17, 2026. Its market cap has decreased by -3.85% in one year.
Market Cap
163.65M
Enterprise Value
71.97M
1-Year Change
-3.85%
Ranking
Category
Stock Price
$1.65
ChartMarket Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $163.65M, a decrease of -81.58%. That is a compound annual growth rate of -28.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 163.65M | 10.12% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NervGen Pharma | 179.48M |
| Milestone Pharmaceuticals | 172.78M |
| OnKure Therapeutics | 170.06M |
| Jyong Biotech | 169.99M |
| Innate Pharma | 169.14M |
| AN2 Therapeutics | 168.20M |
| Corbus Pharmaceuticals Holdings | 166.94M |
| Alector | 166.54M |